記事
Xanthine Oxidase Inhibition by Febuxostat Attenuates Experimental Atherosclerosis in Mice
デジタルデータあり(Crossref)
すぐに読む
CiNii Research
Xanthine Oxidase Inhibition by Febuxostat Attenuates Experimental Atherosclerosis in Mice
- 資料種別
- 記事
- 著者
- Johji Nomuraほか
- 出版者
- Springer Science and Business Media LLC
- 出版年
- 2014-04-01
- 資料形態
- デジタル
- 掲載誌名
- Scientific Reports 4 1
- 掲載ページ
- p.4554-
資料詳細
要約等:
- <jats:title>Abstract</jats:title><jats:p>Atherosclerosis is a chronic inflammatory disease due to lipid deposition in the arterial wall. Multiple mech...
全国の図書館の所蔵
国立国会図書館以外の全国の図書館の所蔵状況を表示します。
所蔵のある図書館から取寄せることが可能かなど、資料の利用方法は、ご自身が利用されるお近くの図書館へご相談ください
書誌情報
この資料の詳細や典拠(同じ主題の資料を指すキーワード、著者名)等を確認できます。
デジタル
- 資料種別
- 記事
- 著者標目
- 出版年月日等
- 2014-04-01
- 出版年(W3CDTF)
- 2014-04-01
- タイトル(掲載誌)
- Scientific Reports
- 巻号年月日等(掲載誌)
- 4 1
- 掲載巻
- 4
- 掲載号
- 1
- 掲載ページ
- 4554-
- 掲載年月日(W3CDTF)
- 2014-04-01
- 出版事項(掲載誌)
- Springer Science and Business Media LLC
- 対象利用者
- 一般
- DOI
- 10.1038/srep04554
- 作成日(W3CDTF)
- 2014-04-01
- 著作権情報
- https://creativecommons.org/licenses/by/3.0/
- 参照
- Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia : A randomized, controlled trialXanthine Oxidase Inhibitor Febuxostat Exerts an Anti-Inflammatory Action and Protects against Diabetic Nephropathy Development in KK-Ay Obese Diabetic MiceFebuxostat treatment attenuates oxidative stress and inflammation due to ischemia-reperfusion injury through the necrotic pathway in skin flap of animal modelThe Effects of Xanthine Oxidoreductase Inhibitors on Oxidative Stress Markers following Global Brain Ischemia Reperfusion Injury in C57BL/6 MiceRole of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic SteatohepatitisThe Xanthine Oxidase Inhibitor Febuxostat Suppresses the Progression of IgA Nephropathy, Possibly via Its Anti-Inflammatory and Anti-Fibrotic Effects in the gddY Mouse ModelFebuxostat Attenuates the Progression of Periodontitis in RatsUrate-lowering therapy for CKD patients with asymptomatic hyperuricemia without proteinuria elucidated by attribute-based research in the FEATHER StudyAllopurinol, Febuxostat, and Nonuse of Xanthine Oxidoreductase Inhibitor Treatment in Patients Receiving Hemodialysis: A Longitudinal AnalysisSignificance and amplification methods of the purine salvage pathway in human brain cellsXOR-Derived ROS in Tie2-Lineage Cells Including Endothelial Cells Promotes Aortic Aneurysm Progression in Marfan SyndromeIncreased plasma XOR activity induced by NAFLD/NASH and its possible involvement in vascular neointimal proliferationFebuxostat reduces muscle wasting in tumor-bearing mice with LM8 osteosarcoma cells via inhibition of reactive oxygen species generationXanthine oxidase inhibition by febuxostat attenuates stress-induced hyperuricemia, glucose dysmetabolism, and prothrombotic state in miceXanthine Oxidase Inhibition by Febuxostat in Macrophages Suppresses Angiotensin II-Induced Aortic FibrosisRole of macrophage autophagy in atherosclerosis: modulation by bioactive compoundsImpact of hyperuricemia on chronic kidney disease and atherosclerotic cardiovascular diseaseAssociation between serum urate level and carotid atherosclerosis: an insight from a post hoc analysis of the PRIZE randomised clinical trialXanthine oxidase inhibitor ameliorates postischemic renal injury in mice by promoting resynthesis of adenine nucleotidesEffect of the Xanthine Oxidase Inhibitor Febuxostat on the Cardio-Ankle Vascular Index in Asymptomatic Patients with Hyperuricemia and Liver Dysfunction: A Sub-Analysis of the PRIZE StudyImpact of Serum Uric Acid Levels on Coronary Plaque Stability Evaluated Using Integrated Backscatter Intravascular Ultrasound in Patients with Coronary Artery DiseaseCardiovascular significance of adipose-derived adiponectin and liver-derived xanthine oxidoreductase in metabolic syndrome
- 連携機関・データベース
- 国立情報学研究所 : CiNii Research
- 提供元機関・データベース
- CrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossrefCrossref